ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia

Leuk Lymphoma. 2019 Feb;60(2):556-558. doi: 10.1080/10428194.2018.1493733. Epub 2018 Aug 30.

Authors

Minghua Cao¹, Ruben D Carrasco¹, Adrian M Dubuc¹, Paola Dal Cin¹, Jonathan A Fletcher¹, Sheng Xiao¹

Affiliation

¹ a Department of Pathology, Brigham and Women's Hospital , Harvard Medical School , Boston ( MA) , USA.

PMID: 30160587
DOI: 10.1080/10428194.2018.1493733

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Biopsy
DNA-Binding Proteins / genetics*
Female
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Karyotype
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / metabolism
Oncogene Proteins, Fusion / genetics*
Receptor, Fibroblast Growth Factor, Type 1 / genetics*
Transcription Factors / genetics*
Translocation, Genetic

Substances

DNA-Binding Proteins
Oncogene Proteins, Fusion
Transcription Factors
ZMYM2 protein, human
FGFR1 protein, human
Receptor, Fibroblast Growth Factor, Type 1